Fresenius Medical Care AG

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Total Revenue $16.6b $17.8b $16.5b $17.5b $17.9b $17.6b $19.4b $19.5b $19.3b $19.6b
Revenue From Interest $141.5m $59.4m $41.1m $52.9m $56.4m $124.8m $69.0m $68.0m
Cost of Goods and Services Sold $11.0b $11.8b $11.4b $12.1b $12.3b $12.5b $14.1b $14.5b $14.6b $14.6b
Gross Profit (derived) $5.6b $6.0b $5.2b $5.4b $5.5b $5.1b $5.3b $4.9b $4.8b $5.0b
Research and development $146.5m $130.7m $114.1m $168.0m $193.8m $220.8m $228.6m $232.0m $183.5m $158.0m
Operating expenses:
Additional Financial Items
General and administrative $2.4b $2.4b $2.4b
Applicable Tax Rate $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Auditors Remuneration For Tax Services $164k $830k $1.1m $318k $1.2m $23k
Average Effective Tax Rate $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Depreciation Right of Use Assets $700.3m $704.0m $690.5m $746.5m $700.7m $675.5m $647.6m
Finance Income $42.1m $43.3m $147.4m $61.6m $42.0m $73.2m $67.7m $88.2m $71.6m $69.6m
Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss $38.3m $119.6m $139.2m $206.7m $37.0m
Other Income $515.2m $760.1m $528.1m
Profit Loss Attributable To Noncontrolling Interests $276.1m $274.7m $243.7m $238.9m $271.5m $249.7m $220.9m $233.5m $203.0m $212.9m
Profit Loss Attributable To Owners Of Parent $1.1b $1.3b $2.0b $1.2b $1.2b $969.3m $673.4m $499.0m $537.9m $978.4m
Profit Loss Before Tax $2.0b $2.0b $2.7b $1.8b $1.9b $1.6b $1.2b $1.0b $1.1b $1.5b
Profit Loss From Operating Activities $2.4b $2.4b $3.0b $2.3b $2.3b $1.9b $1.5b $1.4b $1.4b $1.8b
Share Of Profit Loss Of Associates And Joint Ventures Accounted For Using Equity Method $58.6m $67.2m $73.3m $73.7m $94.5m $92.2m $66.6m $121.8m $134.9m $181.4m
Basic Earnings (Loss) Per Share $3.74 $4.17 $6.47 $3.96 $3.96 $3.31 $2.30 $1.70 $1.83 $3.36
Diluted Earnings (Loss) Per Share $3.73 $4.16 $6.45 $3.96 $3.96 $3.31 $2.30 $1.70 $1.83 $3.36
Selling, General and Administrative Expense $3.1b $3.6b $2.9b $3.1b $3.2b $3.1b $3.8b $3.2b $3.1b $3.0b
Deferred Tax Expense (Income) Recognised In Profit Or Loss ($10.9m) ($203.0m) $89.2m $64.3m $111.1m $67.3m ($41.5m) ($122.1m) ($72.7m) ($27.2m)
Depreciation And Amortisation Expense $724.8m $1.6b $1.6b $1.6b $1.7b $1.6b $1.5b $1.5b
Employee Benefits Expense $6.3b $6.9b $6.4b $6.8b $7.1b $7.0b $7.9b $7.8b $7.8b $7.7b
Expense Relating To Leases Of Low-Value Assets For Which Recognition Exemption Has Been Used $25.2m $27.4m $23.2m $17.4m $22.2m $20.1m $14.2m
Expense Relating To Short-Term Leases For Which Recognition Exemption Has Been Used $52.1m $49.5m $44.9m $52.4m $59.3m $53.1m $65.2m
Expense Relating To Variable Lease Payments Not Included In Measurement Of Lease Liabilities $10.8m $12.4m $12.2m $13.8m $10.5m $6.3m $2.8m
Finance Costs $408.5m $397.2m $448.5m $491.1m $410.0m $353.6m $360.1m $424.6m $407.0m $384.4m
Other Employee Expense $1.3b $1.5b
Postemployment Benefit Expense Defined Benefit Plans $134.6m $147.3m $38.5m $39.2m $50.1m $48.8m $53.8m $55.6m $52.4m $47.1m
Postemployment Benefit Expense Defined Contribution Plans $43.8m $48.7m
Interest Expense $438.0m $486.0m $407.1m $343.8m $359.0m $420.9m $393.3m $375.2m
Interest Expense On Lease Liabilities $171.7m $159.1m $143.2m $151.3m $148.8m $148.4m $143.2m
Income Tax Expense Continuing Operations $622.5m $454.0m $511.1m $401.6m $500.6m $352.8m $325.0m $300.6m $316.1m $321.0m

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.